Project description
Finding a new purpose for old drugs
Bringing new treatments to patients does not only involve new drug discovery. The repurposing of already existing and marketed drugs to treat both common and rare diseases is another viable proposition. The EU-funded DRUGtrain project will develop a paradigm for multidisciplinary research, ideal for improving drug repurposing and development strategies of compounds with autosomal dominant polycystic kidney disease, for example. Specifically, the project will use innovative bioinformatics and cheminformatics approaches to identify potential drug targets and drug candidates for repurposing. It will also perform drug testing/screening in advanced in vitro and in vivo models, ultimately leading to testing of new treatment strategies. DRUGtrain is also developing network activities to boost collaboration between academia, industry and patient organisations.
Field of science
- /medical and health sciences/clinical medicine/nephrology/kidney diseases
Programme(s)
Call for proposal
H2020-MSCA-ITN-2020
See other projects for this call
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
2333 ZA Leiden
Netherlands
Participants (7)
2333 CH Leiden
2340 Beerse
15782 Santiago De Compostela
78464 Konstanz
751 05 Uppsala
M13 9PL Manchester
52074 Aachen
